SYBX (STOCKS)
SYNLOGIC INC
$0.620000
-0.004900 (-0.78%)
Prev close: $0.624900
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Aoife M. Brennan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $42.55M
- Employees
- 1
- P/E (TTM)
- -0.30
- P/B (TTM)
- 0.41
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2024 (Q4)
|
$-0.06 | $-0.10 | +0.0420 | +41.18% |
|
Sep 2024 (Q3)
|
$-0.01 | $-0.18 | +0.1736 | +94.55% |
|
Jun 2024 (Q2)
|
$0.16 | $-0.52 | +0.6802 | +130.76% |
|
Mar 2024 (Q1)
|
$-2.60 | $-0.84 | -1.7636 | -210.86% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $3.00M |
| Operating Expenses | $4.01M |
| Research and Development | $43.00K |
| Other Operating Expenses | $3.97M |
| Operating Income/Loss | -$4.01M |
| Income/Loss From Continuing Operations After Tax | -$1.01M |
| Income/Loss From Continuing Operations Before Tax | -$1.01M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$1.01M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$1.01M |
| Net Income/Loss Available To Common Stockholders, Basic | -$1.01M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.08 |
| Diluted Earnings Per Share | -$0.08 |
| Basic Average Shares | 12,311,909 |
| Diluted Average Shares | 12,311,909 |
| Assets | $15.45M |
| Current Assets | $15.40M |
| Cash | $14.70M |
| Other Current Assets | $697.00K |
| Noncurrent Assets | $50.00K |
| Liabilities | $3.58M |
| Current Liabilities | $3.58M |
| Accounts Payable | $103.00K |
| Wages | $11.00K |
| Other Current Liabilities | $3.47M |
| Noncurrent Liabilities | $0.00 |
| Equity | $11.86M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $11.86M |
| Liabilities And Equity | $15.45M |
| Net Cash Flow From Operating Activities | -$4.36M |
| Net Cash Flow From Operating Activities, Continuing | -$4.36M |
| Net Cash Flow From Investing Activities | $167.00K |
| Net Cash Flow From Investing Activities, Continuing | $167.00K |
| Net Cash Flow From Financing Activities | $4.19M |
| Net Cash Flow From Financing Activities, Continuing | $4.19M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$1.01M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$1.01M |
| Other Comprehensive Income/Loss | $0.00 |